Although PRKDC activation normally supports survival under oxidative conditions, chronic activation, as observed in neurodegenerative diseases such as Alzheimer’s disease, can result in maladaptive signaling characterized by persistent inflammation and the accumulation of damaged cells [63]. The gene discussed is PRKDC; the disease is early-onset autosomal dominant Alzheimer disease.